135 related articles for article (PubMed ID: 2683314)
61. Potential value of antisera to epithelial membrane antigen in detecting early invasion in transitional cell carcinoma.
Pocock RD; Ibrahim SK; Sloane JP; Ponder BA; Shearer RJ
Br J Urol; 1983 Dec; 55(6):670-5. PubMed ID: 6652437
[TBL] [Abstract][Full Text] [Related]
62. Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings.
Aguirre P; Thor AD; Scully RE
Am J Clin Pathol; 1989 Aug; 92(2):140-9. PubMed ID: 2474244
[TBL] [Abstract][Full Text] [Related]
63. Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9.
Kimmel KA; Carey TE
Cancer Res; 1986 Jul; 46(7):3614-23. PubMed ID: 3708592
[TBL] [Abstract][Full Text] [Related]
64. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
[TBL] [Abstract][Full Text] [Related]
65. A comparison of carcinoembryonic antigen (CEA) and epithelial membrane antigen (EMA) in human colorectal cancer.
Davidson BR; Yiu CY; Styles J; Ormerod M; Clark CG; Dean C
Int J Cancer Suppl; 1988; 3():56-60. PubMed ID: 3209300
[TBL] [Abstract][Full Text] [Related]
66. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression.
Iczkowski KA; Shanks JH; Allsbrook WC; Lopez-Beltran A; Pantazis CG; Collins TR; Wetherington RW; Bostwick DG
Histopathology; 1999 Aug; 35(2):150-6. PubMed ID: 10460660
[TBL] [Abstract][Full Text] [Related]
67. Detection of occult nodal metastases in patients with colorectal carcinoma.
Davidson BR; Sams VR; Styles J; Deane C; Boulos PB
Cancer; 1990 Feb; 65(4):967-70. PubMed ID: 2297665
[TBL] [Abstract][Full Text] [Related]
68. Synovial sarcoma. An immunohistochemical study of the epithelial component.
Jørgensen LJ; Lyon H; Myhre-Jensen O; Nordentoft A; Sneppen O
APMIS; 1994 Mar; 102(3):191-6. PubMed ID: 7514419
[TBL] [Abstract][Full Text] [Related]
69. Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.
Ghosh AK; Butler EB
J Clin Pathol; 1987 Dec; 40(12):1424-7. PubMed ID: 3323250
[TBL] [Abstract][Full Text] [Related]
70. Morphometric and immunohistochemical investigation of oral epithelial dysplasia and squamous cell carcinoma.
Sano K
Shika Kiso Igakkai Zasshi; 1989 Aug; 31(4):436-52. PubMed ID: 2519286
[TBL] [Abstract][Full Text] [Related]
71. Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma.
Makboul R; Refaiy A; Abdelkawi IF; Hameed DA; Elderwy AA; Shalaby MM; Merseburger AS; Hussein MR
Pathol Res Pract; 2016 May; 212(5):385-92. PubMed ID: 26916953
[TBL] [Abstract][Full Text] [Related]
72. Are keratin proteins a better tumor marker than epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies.
Pinkus GS; Etheridge CL; O'Connor EM
Am J Clin Pathol; 1986 Mar; 85(3):269-77. PubMed ID: 2428237
[TBL] [Abstract][Full Text] [Related]
73. Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124).
Tungekar MF; Gatter KC; Ritter MA
Br J Cancer; 1996 Feb; 73(4):429-32. PubMed ID: 8595155
[TBL] [Abstract][Full Text] [Related]
74. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
[TBL] [Abstract][Full Text] [Related]
75. Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67.
Okamura K; Miyake K; Koshikawa T; Asai J
J Urol; 1990 Oct; 144(4):875-8. PubMed ID: 2204729
[TBL] [Abstract][Full Text] [Related]
76. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
77. Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer.
Gaisa NT; Braunschweig T; Reimer N; Bornemann J; Eltze E; Siegert S; Toma M; Villa L; Hartmann A; Knuechel R
Virchows Arch; 2011 Mar; 458(3):301-12. PubMed ID: 21136076
[TBL] [Abstract][Full Text] [Related]
78. [The expression of the E-cadherin in human urinary bladder carcinoma].
Miyazaki J; Fujisawa M; Arakawa S; Kamidono S
Nihon Hinyokika Gakkai Zasshi; 1995 Jul; 86(7):1208-15. PubMed ID: 7637235
[TBL] [Abstract][Full Text] [Related]
79. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas.
Hellström I; Hellström KE; Rollins N; Lee VK; Hudkins KL; Nepom GT
Cancer Res; 1985 May; 45(5):2210-8. PubMed ID: 3986770
[TBL] [Abstract][Full Text] [Related]
80. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
Sinard JH
Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
